エソテリック検査市場：技術、タイプ、機能、エンドユーザー別-2025～2030年の世界予測

エソテリック検査市場は、2023年に328億5,000万米ドルと評価され、2024年には355億6,000万米ドルに達すると予測され、CAGR 8.46％で成長し、2030年には580億2,000万米ドルに達すると予測されています。

エソテリック検査には、日常的には実施されず、しばしば特殊な機器や技術を必要とする臨床検査が含まれます。これらの検査は通常、遺伝子疾患や感染症など、より複雑で一般的でない病状に用いられます。エソテリック検査の必要性は、個別化医療の進歩や、より的を絞った治療計画の指針となる遺伝子マーカーの深い理解により、著しく高まっています。用途では、難解な検査は特に腫瘍学、内分泌学、遺伝学、感染症などの領域で極めて重要です。最終用途の範囲には主に病院、診断ラボ、研究機関、学術施設が含まれます。

エソテリック検査市場は、慢性疾患の有病率の上昇、分子・遺伝子検査における技術進歩、医療提供者の意識の高まりなど、いくつかの重要な要因によって成長しています。さらに、医療インフラの拡大や研究開発への投資の増加は、潜在的なビジネス機会を浮き彫りにしています。より正確なデータ解釈のための人工知能と機械学習の統合は、技術革新の大きな機会となります。しかし、この市場が直面する主要制約の1つは、難解な検査に関連する高コストであり、これがアクセシビリティを制限する可能性があります。規制上のハードルと償還の課題も、普及の大きな障壁となっています。

このような課題にもかかわらず、技術革新の余地があるセグメントには、より費用対効果の高い検査法の開発、これらの検査の感度と特異度の向上、疾患の進行状況のリアルタイムモニタリングへの応用範囲の拡大などがあります。企業は、学術・研究機関と提携して遺伝子・分子検査における最先端のイノベーションを活用することで、知見を得ることができます。市場は、既存参入企業と新規参入参入企業の両方が市場シェアを争う競合情勢を特徴としています。規制環境を効果的に乗り切りながら、技術的進歩を推し進めることができる企業は、大きな進出を果たす可能性が高いです。全体として、市場力学はダイナミックに進化する市場であり、革新と適応の態勢を整えた企業には大きなビジネス機会があります。

市場力学：急速に進化するエソテリック検査市場の主要市場洞察を公開

エソテリック検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 消費者の希少疾患に対する意識の高まり
  • 慢性疾患と高齢者の世界の増加
• 市場抑制要因
  • 難解な検査の入手可能性・利用可能性が限られることによるコスト高
• 市場機会
  • 医療システム改善のための政府による多額の投資
  • 非侵襲的検査法の開発とともに、個別化医療が大幅に成長
• 市場課題
  • エソテリック検査法を管理するために規制当局が設定した厳しい規則と基準

ポーターのファイブフォース：エソテリック検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、エソテリック検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：エソテリック検査市場における外部からの影響の把握

外部マクロ環境要因は、エソテリック検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：エソテリック検査市場における競合情勢の把握

エソテリック検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：エソテリック検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、エソテリック検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：エソテリック検査市場における成功への道筋を描く

エソテリック検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 消費者の希少疾患に対する意識向上
    • 世界中で慢性疾患の有病率と高齢者の増加
  • 抑制要因
    • 難解な検査の利用可能性とアクセス性が制限され、コストが高くなる
  • 機会
    • 医療制度の改善のために政府が行った多額の投資
    • 非侵襲的検査方法の開発とともに、個別化医療の大幅な成長
  • 課題
    • エソテリック検査メソッドを制御するために規制当局が設定した厳格な規則と基準
• 市場セグメンテーション分析
  • 技術：診断、ワクチン開発、品質管理におけるELISA検査に対するエンドユーザーの信頼性
  • エンドユーザー：病院施設におけるエソテリック検査の使用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 エソテリック検査市場：技術別

• イントロダクション
• 化学発光免疫測定法
• DNA配列分析
• 酵素免疫測定法
• フローサイトメトリー
• 質量分析
• リアルタイムPCR

第7章 エソテリック検査市場：タイプ別

• イントロダクション
• 内分泌検査
• 遺伝子検査
• 免疫学的検査
• 感染症検査
• 神経学的検査
• 腫瘍学検査
• 毒性検査

第8章 エソテリック検査市場：機能別

• イントロダクション
• 診断検査
• モニタリング検査
• 予測検査
• 予後検査

第9章 エソテリック検査市場：エンドユーザー別

• イントロダクション
• 学術機関
• 診断ラボ
• 病院
• 研究機関

第10章 南北アメリカのエソテリック検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のエソテリック検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのエソテリック検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Medirom Healthcare、遺伝子治療への進出と健康サービス強化のためJapan GENE Medicineを買収
  • Thermo FisherとNCIが遺伝子配列分析と精密医療で骨髄がん治療に革命を起こすために提携
  • Aegis Sciences CorporationがHealthTrackRxの毒性学部門を買収し毒性学サービスを拡大、HealthTrackRxはRT-PCR感染症検査に重点を移行
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Adaptive BIoTechnologies Corporation
• ARUP Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• Centogene N.V.
• Clarient Diagnostic Services, Inc.
• F. Hoffmann-La Roche AG
• Foundation Medicine, Inc.
• Genomic Health, Inc.
• Guardant Health, Inc.
• ICON plc
• IGM Biosciences, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings
• Myriad Genetics, Inc.
• Natera, Inc.
• NeoGenomics Laboratories, Inc.
• Opko Health, Inc.
• PerkinElmer, Inc.
• Qiagen N.V.
• Quest Diagnostics Incorporated
• Regeneron Pharmaceuticals, Inc.
• Siemens Healthineers AG
• Sonic Healthcare Limited
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Veracyte, Inc.

LIST OF FIGURES

• FIGURE 1. ESOTERIC TESTING MARKET RESEARCH PROCESS
• FIGURE 2. ESOTERIC TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ESOTERIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ESOTERIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ESOTERIC TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ESOTERIC TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ESOTERIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ESOTERIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ESOTERIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ESOTERIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ESOTERIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ESOTERIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ESOTERIC TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ESOTERIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ESOTERIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ESOTERIC TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ESOTERIC TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ESOTERIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ESOTERIC TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ESOTERIC TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ESOTERIC TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ESOTERIC TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ESOTERIC TESTING MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ESOTERIC TESTING MARKET SIZE, BY GENETICS TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ESOTERIC TESTING MARKET SIZE, BY IMMUNOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ESOTERIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ESOTERIC TESTING MARKET SIZE, BY NEUROLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ESOTERIC TESTING MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ESOTERIC TESTING MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ESOTERIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ESOTERIC TESTING MARKET SIZE, BY MONITORING TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ESOTERIC TESTING MARKET SIZE, BY PREDICTIVE TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ESOTERIC TESTING MARKET SIZE, BY PROGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ESOTERIC TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ESOTERIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ESOTERIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ESOTERIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES ESOTERIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. CHINA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. INDIA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. PHILIPPINES ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SINGAPORE ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 94. SINGAPORE ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. SOUTH KOREA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 98. SOUTH KOREA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. TAIWAN ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 102. TAIWAN ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. THAILAND ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 106. THAILAND ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. VIETNAM ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 110. VIETNAM ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA ESOTERIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. DENMARK ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 119. DENMARK ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. EGYPT ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 123. EGYPT ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. FINLAND ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 127. FINLAND ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. FRANCE ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 131. FRANCE ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. GERMANY ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 135. GERMANY ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. ISRAEL ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 139. ISRAEL ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. ITALY ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. ITALY ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. ITALY ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 143. ITALY ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NETHERLANDS ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 147. NETHERLANDS ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. NIGERIA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 151. NIGERIA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. NORWAY ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 155. NORWAY ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. POLAND ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. POLAND ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. POLAND ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 159. POLAND ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. QATAR ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. QATAR ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. QATAR ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 163. QATAR ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. RUSSIA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 167. RUSSIA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SAUDI ARABIA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 171. SAUDI ARABIA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH AFRICA ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH AFRICA ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SPAIN ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 179. SPAIN ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. SWEDEN ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 183. SWEDEN ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. SWITZERLAND ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 187. SWITZERLAND ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. TURKEY ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 191. TURKEY ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. UNITED ARAB EMIRATES ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 195. UNITED ARAB EMIRATES ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM ESOTERIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM ESOTERIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. UNITED KINGDOM ESOTERIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 199. UNITED KINGDOM ESOTERIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. ESOTERIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 201. ESOTERIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Esoteric Testing Market was valued at USD 32.85 billion in 2023, expected to reach USD 35.56 billion in 2024, and is projected to grow at a CAGR of 8.46%, to USD 58.02 billion by 2030.

Esoteric testing involves laboratory tests that are not routinely performed and often require specialized equipment or technology. These tests are typically used for more complex or less common medical conditions, like genetic disorders or infectious diseases. The necessity for esoteric testing has grown significantly due to advances in personalized medicine and a deeper understanding of genetic markers that can guide more targeted treatment plans. In application, esoteric tests are crucial in the domains of oncology, endocrinology, genetics, and infectious diseases, among others. The end-use scope predominantly includes hospitals, diagnostic laboratories, research institutes, and academic facilities.

The market for esoteric testing is growing due to several key factors, such as the rising prevalence of chronic diseases, technological advancements in molecular and genetic testing, and increased awareness among healthcare providers. Moreover, the expansion of healthcare infrastructure and increasing investments in research and development highlight potential opportunities. The integration of artificial intelligence and machine learning for more accurate data interpretation represents a substantial opportunity for innovation. However, one of the primary limitations facing this market is the high cost associated with esoteric tests, which can limit accessibility. Regulatory hurdles and reimbursement challenges also pose significant barriers to widespread adoption.

Despite these challenges, areas ripe for innovation include the development of more cost-effective testing methods, enhancing the sensitivity and specificity of these tests, and expanding the application scope to include real-time monitoring of disease progress. Businesses can gain insight by partnering with academic and research institutions to leverage cutting-edge innovations in genetic and molecular testing. The market is characterized by a competitive landscape with both established players and new entrants vying for market share. Companies that can navigate the regulatory environment effectively while pushing the envelope in technological advancements are likely to make significant inroads. Overall, esoteric testing represents a dynamic and evolving market with substantial opportunities for those poised to innovate and adapt.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Esoteric Testing Market

The Esoteric Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness of rare diseases among consumers
  • Higher prevalence of chronic disorders and geriatric population across the world
• Market Restraints
  • Higher cost with limited availability and accessibility of the esoteric tests
• Market Opportunities
  • Significant investments made by the government to improve the healthcare system
  • Substantial growth in personalized medicine, along with the development of non-invasive testing methods
• Market Challenges
  • Stringent rules and standards set by the regulatory authorities to control esoteric testing methods

Porter's Five Forces: A Strategic Tool for Navigating the Esoteric Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Esoteric Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Esoteric Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Esoteric Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Esoteric Testing Market

A detailed market share analysis in the Esoteric Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Esoteric Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Esoteric Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Esoteric Testing Market

A strategic analysis of the Esoteric Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Esoteric Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, ARUP Laboratories, Inc., Bio-Rad Laboratories, Inc., Centogene N.V., Clarient Diagnostic Services, Inc., F. Hoffmann-La Roche AG, Foundation Medicine, Inc., Genomic Health, Inc., Guardant Health, Inc., ICON plc, IGM Biosciences, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Natera, Inc., NeoGenomics Laboratories, Inc., Opko Health, Inc., PerkinElmer, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Regeneron Pharmaceuticals, Inc., Siemens Healthineers AG, Sonic Healthcare Limited, Sysmex Corporation, Thermo Fisher Scientific Inc., and Veracyte, Inc..

Market Segmentation & Coverage

This research report categorizes the Esoteric Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Chemiluminescence Immunoassay, DNA Sequencing, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Mass Spectrometry, and Real-Time PCR.
• Based on Type, market is studied across Endocrinology Testing, Genetics Testing, Immunology Testing, Infectious Diseases Testing, Neurology Testing, Oncology Testing, and Toxicology Testing.
• Based on Function, market is studied across Diagnostic Tests, Monitoring Tests, Predictive Tests, and Prognostic Tests.
• Based on End-User, market is studied across Academic Institutions, Diagnostic Laboratories, Hospitals, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness of rare diseases among consumers
    • 5.1.1.2. Higher prevalence of chronic disorders and geriatric population across the world
  • 5.1.2. Restraints
    • 5.1.2.1. Higher cost with limited availability and accessibility of the esoteric tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Significant investments made by the government to improve the healthcare system
    • 5.1.3.2. Substantial growth in personalized medicine, along with the development of non-invasive testing methods
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent rules and standards set by the regulatory authorities to control esoteric testing methods
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: End-users' reliability on ELISA tests in diagnostics, vaccine development, and quality control
  • 5.2.2. End-User: Growing usage of esoteric testing in hospital facilities
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Esoteric Testing Market, by Technology

• 6.1. Introduction
• 6.2. Chemiluminescence Immunoassay
• 6.3. DNA Sequencing
• 6.4. Enzyme-Linked Immunosorbent Assay
• 6.5. Flow Cytometry
• 6.6. Mass Spectrometry
• 6.7. Real-Time PCR

7. Esoteric Testing Market, by Type

• 7.1. Introduction
• 7.2. Endocrinology Testing
• 7.3. Genetics Testing
• 7.4. Immunology Testing
• 7.5. Infectious Diseases Testing
• 7.6. Neurology Testing
• 7.7. Oncology Testing
• 7.8. Toxicology Testing

8. Esoteric Testing Market, by Function

• 8.1. Introduction
• 8.2. Diagnostic Tests
• 8.3. Monitoring Tests
• 8.4. Predictive Tests
• 8.5. Prognostic Tests

9. Esoteric Testing Market, by End-User

• 9.1. Introduction
• 9.2. Academic Institutions
• 9.3. Diagnostic Laboratories
• 9.4. Hospitals
• 9.5. Research Institutes

10. Americas Esoteric Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Esoteric Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Esoteric Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Medirom Healthcare Acquires Japan GENE Medicine to Expand Into Gene Therapy and Enhance Wellness Services
  • 13.3.2. Thermo Fisher and NCI Partner to Revolutionize Myeloid Cancer Treatment with Genetic Sequencing and Precision Medicine
  • 13.3.3. Aegis Sciences Corporation Acquires HealthTrackRx's Toxicology Unit to Expand Toxicology Services, HealthTrackRx Shifts Focus to RT-PCR Infectious Disease Testing
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Adaptive Biotechnologies Corporation
• 3. ARUP Laboratories, Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. Centogene N.V.
• 6. Clarient Diagnostic Services, Inc.
• 7. F. Hoffmann-La Roche AG
• 8. Foundation Medicine, Inc.
• 9. Genomic Health, Inc.
• 10. Guardant Health, Inc.
• 11. ICON plc
• 12. IGM Biosciences, Inc.
• 13. Invitae Corporation
• 14. Laboratory Corporation of America Holdings
• 15. Myriad Genetics, Inc.
• 16. Natera, Inc.
• 17. NeoGenomics Laboratories, Inc.
• 18. Opko Health, Inc.
• 19. PerkinElmer, Inc.
• 20. Qiagen N.V.
• 21. Quest Diagnostics Incorporated
• 22. Regeneron Pharmaceuticals, Inc.
• 23. Siemens Healthineers AG
• 24. Sonic Healthcare Limited
• 25. Sysmex Corporation
• 26. Thermo Fisher Scientific Inc.
• 27. Veracyte, Inc.